🇺🇸 FDA
Patent

US 10421798

Factor VIII compositions and methods of making and using same

granted A61KA61K38/00A61P

Quick answer

US patent 10421798 (Factor VIII compositions and methods of making and using same) held by BIOVERATIV THERAPEUTICS INC. expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
44
CPC classes
A61K, A61K38/00, A61P, A61P7/00, A61P7/02